| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
28,440,000 |
| Market
Cap: |
8.88(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.267 - $4.6101 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Moleculin Biotech is a clinical stage pharmaceutical company. Co.'s technologies include: Annamycin, an anthracycline designed to be different than existing approved anthracyclines by eliminating cardiotoxicity and avoiding the multidrug resistance mechanisms that can limit the efficacy of the approved products; WP1066 Portfolio, which includes WP1066 and WP1220, two of several Immune/Transcription Modulators in the portfolio designed to inhibit phosphorylated signal transducer and activator of transcription among other transcription factors associated with tumor activity, while also stimulating a natural immune response to tumors by inhibiting the errant activity of Regulatory T-Cells.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
945,945 |
945,945 |
945,945 |
1,177,828 |
| Total Buy Value |
$350,000 |
$350,000 |
$350,000 |
$509,999 |
| Total People Bought |
2 |
2 |
2 |
3 |
| Total Buy Transactions |
2 |
2 |
2 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Klemp Walter V |
CEO and President |
• • – |
2025-06-23 |
4 |
B |
$0.37 |
$250,000 |
D/D |
675,675 |
743,607 |
2.81 |
18% |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2025-06-23 |
4 |
B |
$0.37 |
$100,000 |
D/D |
270,270 |
287,587 |
2.74 |
18% |
|
| Klemp Walter V |
CEO and President |
• • – |
2025-06-22 |
4 |
D |
$0.27 |
$585 |
D/D |
(2,190) |
67,932 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2025-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,990 |
70,122 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2025-06-22 |
4 |
D |
$0.27 |
$281 |
D/D |
(1,054) |
17,317 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2025-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,328 |
18,371 |
|
- |
|
| Picker Donald H |
Chief Science Officer |
• • – |
2025-06-22 |
4 |
D |
$0.27 |
$115 |
D/D |
(430) |
10,152 |
|
- |
|
| Picker Donald H |
Chief Science Officer |
• • – |
2025-06-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,766 |
10,582 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2025-06-20 |
4 |
D |
$0.27 |
$244 |
D/D |
(914) |
61,132 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2025-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
62,046 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2025-06-20 |
4 |
D |
$0.27 |
$176 |
D/D |
(661) |
14,043 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2025-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,711 |
14,704 |
|
- |
|
| Picker Donald H |
Chief Science Officer |
• • – |
2025-06-20 |
4 |
D |
$0.27 |
$70 |
D/D |
(263) |
8,816 |
|
- |
|
| Picker Donald H |
Chief Science Officer |
• • – |
2025-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,078 |
9,079 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2025-06-16 |
4 |
D |
$0.69 |
$139 |
D/D |
(203) |
11,993 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2025-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
833 |
12,196 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2025-06-16 |
4 |
D |
$0.69 |
$278 |
D/D |
(406) |
58,296 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2025-06-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,667 |
58,702 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2024-07-02 |
4 |
D |
$3.57 |
$857 |
D/D |
(240) |
57,035 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2024-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
982 |
57,275 |
|
- |
|
| Picker Donald H |
Chief Science Officer |
• • – |
2024-06-20 |
4 |
D |
$3.78 |
$1,210 |
D/D |
(320) |
6,759 |
|
- |
|
| Picker Donald H |
Chief Science Officer |
• • – |
2024-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,078 |
7,079 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2024-06-20 |
4 |
D |
$3.78 |
$2,404 |
D/D |
(636) |
8,087 |
|
- |
|
| Foster Jonathan P. |
Chief Financial Officer |
• • – |
2024-06-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,712 |
8,723 |
|
- |
|
| Klemp Walter V |
CEO and President |
• • – |
2024-06-20 |
4 |
D |
$3.78 |
$3,455 |
D/D |
(914) |
49,493 |
|
- |
|
73 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.01 (3.04%) 
